 Primary sclerosing cholangitis, PSC, is a rare chronic inflammatory disorder of the bile ducts that can lead to cirrhosis and liver failure if left untreated. It is often seen in conjunction with other autoimmune diseases such as ulcerative colitis or Crohn's disease. The most common treatment for PSC is a liver transplant, but there are limited data on the effectiveness of different types of transplants. This study looked at the differences in survival rates between deceased donor liver transplants, DDLT, and living donor liver transplants, LDLT, in PSC patients. The results showed that LDLT was associated with higher patient and graph survival rates compared to DDLT. Additionally, Asian patients were found to have lower mortality rates than Caucasian patients. This article was authored by Leandro Sierra, Vermelia Barba, Brian Ferrigno, and others.